“The blockbuster weight loss drug Wegovy is now approved to reduce heart
disease risk, drugmaker Novo Nordisk said Friday… The change comes
after, in a late-stage clinical trial of more than 17,000 adults, Novo
Nordisk found that Wegovy cut the risk of cardiovascular events — such
as heart attack and stroke — by 20% compared […]
The post FDA Approves Wegovy to Reduce Heart Attack and Stroke Risk
appeared first on Human Progress.
https://humanprogress.org/fda-approves-wegovy-to-reduce-heart-attack-and-stroke-risk/View article
View summary
